192 related articles for article (PubMed ID: 35021969)
1. WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2.
Khan A; Wei DQ
Comb Chem High Throughput Screen; 2022 Jan; ():. PubMed ID: 35021969
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.
Ganna I; Anna S
Curr Cardiol Rev; 2022 May; ():. PubMed ID: 35570515
[TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Therapeutic Targeted Approaches for Covid-19 Treatment.
Rajawat J; Misra G; Anvikar AK; Era B
Curr Pharm Biotechnol; 2022 Mar; ():. PubMed ID: 35249480
[TBL] [Abstract][Full Text] [Related]
4. WITHDRAWN: Main Diagnostic Methods for COVID-19: Integrative Review.
de Campos ASM; de Souza GAF; de Jesus RA; Zardeto G; Donadel G; Dalmagro M; de Almeida Canoff JR; Hoscheid J; Alberton O; Boleta-Ceranto DCF; Gonçalves DD; Botelho Lourenço EL; Cogo J
Curr Pharm Des; 2022 May; ():. PubMed ID: 35619252
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Conjugation of Ruthenium Drugs to Nanocellulose using Boronic Ester.
Lu M; Khine YY; Shen Y; Stenzel MH
Curr Drug Deliv; 2023 Feb; ():. PubMed ID: 36797605
[TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Recent Advances of Nanotechnology in the Treatment of Skin Cancer.
Kanugo A
Curr Pharm Biotechnol; 2022 Apr; ():. PubMed ID: 35379144
[TBL] [Abstract][Full Text] [Related]
7. WITHDRAWN: Moderna’s COVID 19 Patent Under the Magnifying Glass.
Storz U
Recent Pat Biotechnol; 2022 Jun; ():. PubMed ID: 35713124
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Recent Advances and Reports on Encapsulation in the Food Matrix: A Review.
Potdar SB; Saudagar P; Potoroko I; Bagale U; Sonawane S; Sonawane SH
Curr Pharm Biotechnol; 2022 May; ():. PubMed ID: 35570555
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Comparing Nucleated Red Blood Cells in Neonates with and without Retinopathy.
Boskabadi H; Pourbadakhshan N; Pishghadam E; Zakerihamidi M
Curr Pediatr Rev; 2021 Sep; ():. PubMed ID: 34503429
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Nucleic Acid-Based Vaccines Platform Against Covid-19 Pandemic.
Baghban R; Mahmoodi S
Curr Mol Med; 2022 Jan; ():. PubMed ID: 34994327
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Scrutinizing the Role of Genetically Modified Herbs (GMHs) in the Treatment of Various Diseases.
Sindhu RK; Verma R; Salgotra T; Madaan P; Chandel P; Batiha GE; Cavalu S
Recent Pat Biotechnol; 2022 May; ():. PubMed ID: 35549856
[TBL] [Abstract][Full Text] [Related]
12. WITHDRAWN: Smart Trends: Liposome-Based Nanocarriers for Cancer Treatment and its Applications.
Khatoon R; Huda S; Alam MA
Pharm Nanotechnol; 2022 Feb; ():. PubMed ID: 35142276
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Salmonella typhi: A Review of Antibiogram Journey in Developing Countries.
Singhal L; Sandhu D; Kour I; Gupta V
Infect Disord Drug Targets; 2022 Jun; ():. PubMed ID: 35692133
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Impact of Racial Differences on the Epidemiology and Clinical Outcomes of Atrial Fibrillation.
Quah JX; Dharmaprani D; Tiver K; McGavigan AD; Ganesan AN
Curr Cardiol Rev; 2021 Dec; ():. PubMed ID: 34886777
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Ivabradine for Uncontrolled Sinus Tachycardia in Thyrotoxic Cardiomyopathy – Case Report.
Frenkel A; Bichovsky Y; Arotsker N; Besser L; Joshua BZ; Fraenkel M; Zahger D; Klein M
Endocr Metab Immune Disord Drug Targets; 2021 Sep; ():. PubMed ID: 34544353
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Imaging Features of Primary Non-Hodgkin’s Lymphoma of Long Bones.
Han ZW; Wu Y; Han SM; Cao L; Liu C; Yang C; Yang HH; Wu WJ; Gao BL; Yu BH
Curr Med Imaging; 2023 Feb; ():. PubMed ID: 36733202
[TBL] [Abstract][Full Text] [Related]
17. WITHDRAWN: Hydroxysafflor Yellow A Ameliorates Toll-like Receptor 4-Mediated Septic Cardiomyopathy.
Yuan L; Geng H; Gu X; Ma Y; Sun F; Xiong Q; Zhang T
Curr Drug Deliv; 2022 Apr; ():. PubMed ID: 35422215
[TBL] [Abstract][Full Text] [Related]
18. WITHDRAWN: Pulmonary Nocardiosis Caused by Nocardia otitidiscaviarum in an Immunocompromised Patient and Its Review of Literature.
Srivastava S; Samaddar A; Tak V; Khan S; Bohra GK; Sharma D; Ghosh A; Nag VL
Infect Disord Drug Targets; 2022 Jan; ():e180122200336. PubMed ID: 35040421
[TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Specialized Pro-resolving Lipid Mediators: Endogenous Regulation of Vascular Inflammation and Remodeling.
Liu L; Zhao A; Qian L; Wang J
Curr Pharm Des; 2022 Jul; ():. PubMed ID: 35894457
[TBL] [Abstract][Full Text] [Related]
20. WITHDRAWN: Application of Chemotherapeutic Drugs and Convectionenhanced Delivery Technology in Glioma.
Zhou Y; Xue Y; Ye F; Huang J; Wang L; Wang W
Anticancer Agents Med Chem; 2023 May; ():. PubMed ID: 37198987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
